Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report)’s share price fell 1.5% on Monday . The company traded as low as $0.32 and last traded at $0.36. 4,880 shares changed hands during trading, a decline of 75% from the average session volume of 19,397 shares. The stock had previously closed at $0.36.
Alpha Tau Medical Trading Down 1.5%
The stock’s 50-day simple moving average is $0.28 and its two-hundred day simple moving average is $0.25.
Alpha Tau Medical Company Profile
(Get Free Report)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company’s Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Further Reading
Five stocks we like better than Alpha Tau Medical
Insider Trades May Not Tell You What You Think
Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
Market Cap Calculator: How to Calculate Market Cap
Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
Top Stocks Investing in 5G Technology
This ETF Weeds Out Small-Cap Underperformers
Alpha Tau Medical (NASDAQ:DRTSW) Shares Down 1.5% – Here’s Why
